26.01.2015 Views

Tax Efficient Review of Octopus Eureka EIS Fund with ... - Clubfinance

Tax Efficient Review of Octopus Eureka EIS Fund with ... - Clubfinance

Tax Efficient Review of Octopus Eureka EIS Fund with ... - Clubfinance

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Track Record<br />

made by the <strong>Octopus</strong> <strong>Fund</strong> Managers. This endorsement comes through the potential<br />

investee company presenting directly to a group <strong>of</strong> the VPs. Ultimately, unless a reasonable<br />

number <strong>of</strong> VPs commit to invest into a deal (typically 5-15% <strong>of</strong> the capital for each deal comes<br />

from the VPs) <strong>Octopus</strong> will not invest. <strong>Octopus</strong> sites this as being one <strong>of</strong> the key ways in which<br />

they mitigate risk.<br />

4. Post-investment <strong>Octopus</strong> works actively <strong>with</strong> its portfolio companies in order to maximise<br />

the value from each investment. The VPs provide a significant and valuable resource in this<br />

process. Often VP members will sit on the Boards <strong>of</strong> investee companies or act as <strong>Octopus</strong>’<br />

observer/monitor <strong>with</strong>in that company.<br />

The aim <strong>of</strong> this <strong>EIS</strong> <strong>of</strong>fering is to create a diversified portfolio <strong>of</strong> investments in early stage unquoted<br />

companies <strong>with</strong> a focus on the environmental, technology, media, telecoms, consumer lifestyle and<br />

wellbeing sectors.<br />

A key number for potential investors in an <strong>EIS</strong> <strong>Fund</strong> <strong>of</strong>fering is the amount that, after costs, will be<br />

invested in the underlying <strong>EIS</strong> qualifying companies as this number will drive the initial income tax relief<br />

and any amount <strong>of</strong> deferred CGT. <strong>Octopus</strong> tells us "Our estimate is that the amount invested into qualifying<br />

companies will be approximately £92,000 assuming that the IFA rebates the commission" (see Table 5).<br />

We asked <strong>Octopus</strong> for its view <strong>of</strong> the time taken from the investment to investors receiving <strong>EIS</strong><br />

certificates. Their response is "It is expected that investors will receive the <strong>EIS</strong> 3 certificates approximately<br />

3 months after investment into each <strong>of</strong> the qualifying companies".<br />

<strong>Tax</strong> <strong>Efficient</strong> <strong>Review</strong> Strategy rating: 28 out <strong>of</strong> 30<br />

This is an <strong>of</strong>fering from <strong>Octopus</strong> that has been established for 3.5 years now (<strong>with</strong> a different<br />

strategy to previous <strong>Eureka</strong> <strong>EIS</strong> fund raisings). During this period, the economic conditions have altered<br />

substantially <strong>with</strong> the credit crunch and economic upheaval effecting stock markets globally.<br />

A total <strong>of</strong> 26 qualifying investments made into unquoted companies in this time (Table 4) and 9<br />

into AIM listed companies (Table 5). The aggregate investment by <strong>Eureka</strong> into all <strong>of</strong> the companies<br />

managed by the Ventures team totals £11.392m.<br />

The <strong>Eureka</strong> portfolio (Table 6) <strong>of</strong> 26 unquoted investments made by the Ventures team now has<br />

three fully written-down, three impaired, increases in value from four <strong>of</strong> the businesses and the<br />

remaining sixteen held at cost.<br />

As these businesses are unquoted (<strong>with</strong> the exception <strong>of</strong> e-Therapeutics) they are valued in accordance<br />

<strong>with</strong> International Private Equity and Venture Capital Guidelines. In the case <strong>of</strong> the <strong>Eureka</strong><br />

investments, this means the valuation <strong>of</strong> a business is generally left at cost unless a further funding<br />

round has taken place or the performance has been poor. If a further funding has taken place,<br />

the investment will be re-valued up or down to reflect the most recent issue price. The investment<br />

will also be re-valued if there has been an impairment to trading or an impairment in the business’<br />

outlook. Here the valuation <strong>of</strong> the investment will be reduced at the six monthly re-valuation<br />

dates even though no share transaction may have taken place. On this basis, the <strong>Eureka</strong> portfolio<br />

managed by the Ventures team is currently valued at £11.412m <strong>with</strong> a cost price <strong>of</strong> £11.392m. Full<br />

details are in Table 4.<br />

Looking at the individual companies, it is perhaps worth considering two in particular. Zoopla,<br />

an investment made in January 2009, is now the UK’s second most visited website after Rightmove<br />

(Source: Nielson). Whilst significant in size, Rightmove is a listed business valued at over £1.2bn.<br />

Meanwhile, Calastone, the mutual messaging service, releases an announcement regarding new<br />

clients on an increasingly regular basis as more and more <strong>of</strong> the industry adopts the service (Source:<br />

Calastone press announcements).<br />

The AIM team have made 9 investments since <strong>Eureka</strong> was relaunched in May 2008. The total<br />

capital deployed into these investments is £4.481m. Full details <strong>of</strong> the AIM investments are detailed<br />

in Table 6. Performance for the AIM investments is straightforward as this is a quoted market.<br />

Overall the performance <strong>of</strong> the <strong>Eureka</strong> <strong>of</strong>fering has not been stellar and, <strong>with</strong> no exits so far from<br />

those investments specifically made as <strong>EIS</strong> investments, we rate the <strong>Eureka</strong> performance inferior to<br />

10 <strong>Tax</strong> <strong>Efficient</strong> <strong>Review</strong> Reprinted for the use <strong>of</strong> <strong>Octopus</strong> Investments Limited November 2011

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!